Company: LICN
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001213900-25-036244
Chunk: 10

Company: Lichen International Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 4
Chunk 10
---
have been exercised in full and the Company has issued 9,566,667 Class A Ordinary Shares as a result of such exercise.

The First Closing Shares,
the First Closing Pre-Funded Warrants and the Class A Ordinary Shares underlying the First Closing Pre-funded Warrants (together with
the First Closing Shares and the First Closing Pre-Funded Warrants, the “ First Closing Securities”) were offered by the Company
pursuant to a registration statement on Form F-3 (File No. 333-277230) (the “ Registration Statement”), previously filed and
declared effective by the Securities and Exchange Commission (the “ Commission”) on March 1, 2024, the base prospectus filed
as part of the Registration Statement, and the prospectus supplement dated December 26, 2024 (the “ First Prospectus Supplement”).

On December 26, 2024, the
Company entered into a placement agency agreement (the “ First Closing Placement Agency Agreement”) withUnivest
Securities, LLC(“ Univest” or the “ Placement Agent”),
pursuant to which the Company engaged Univestas the exclusive placement agent
in connection with December 26 Registered Direct Offering. The Placement Agent agreed to use its reasonable best efforts to arrange for
the sale of the First Closing Shares and the First Closing Pre-Funded Warrants. In addition, under the First Closing Placement Agency
Agreement the Company agreed to pay the Placement Agent a placement agent fee in cash equal to seven percent (7.0%) of the aggregate gross
proceeds raised from the sale. The Company also agreed to reimburse the Placement Agent at closing for legal and other expenses incurred
by them in connection with December 26 Registered Direct Offering in an amount not to exceed $50,000.

December 29, 2024 Registered Direct Offering

On December 29, 2024, the
Company entered into a securities purchase agreement (the “ Second Closing Purchase Agreement”) with the same Purchasers, pursuant
to which the Company agreed to issue and sell, in a registered direct offering ( “ December 29 Registered Direct Offering”):
(i) 13,200,000 Class A Ordinary Shares (the “ Second Closing Shares”), at a purchase price of $0.125 per share; and (ii) pre-funded
warrants to purchase up to 11,800,000 Class A Ordinary Shares (the “ Second Closing Pre-Funded Warrants”) at a purchase price
of $0.